Resistance to the Antibody-Drug Conjugate T-DM1 Is Based in a Reduction in Lysosomal Proteolytic Activity

Show simple item record

dc.contributor.author Ríos-Luci, C.
dc.contributor.author García-Alonso, S.
dc.contributor.author Díaz-Rodríguez, E.
dc.contributor.author Nadal-Serrano, M.
dc.contributor.author Arribas, J.
dc.contributor.author Ocaña, A.
dc.contributor.author Pandiella, A.
dc.date.accessioned 2024-02-06T09:41:14Z
dc.date.available 2024-02-06T09:41:14Z
dc.identifier.uri http://hdl.handle.net/11201/164551
dc.description.abstract -
dc.format application/pdf
dc.relation.isformatof Versió postprint del document publicat a: https://doi.org/10.1158/0008-5472.CAN-16-3127
dc.relation.ispartof Cancer Research, 2017, vol. 77, num. 17, p. 4639-4651
dc.subject.classification 57 - Biologia
dc.subject.classification Ciències de la salut
dc.subject.other 57 - Biological sciences in general
dc.subject.other Medical sciences
dc.title Resistance to the Antibody-Drug Conjugate T-DM1 Is Based in a Reduction in Lysosomal Proteolytic Activity
dc.type info:eu-repo/semantics/article
dc.type info:eu-repo/semantics/acceptedVersion
dc.date.updated 2024-02-06T09:41:14Z
dc.rights.accessRights info:eu-repo/semantics/openAccess
dc.identifier.doi https://doi.org/10.1158/0008-5472.CAN-16-3127


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search Repository


Advanced Search

Browse

My Account

Statistics